Welcome to our dedicated page for T Rowe Price Grp SEC filings (Ticker: TROW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The T. Rowe Price Group, Inc. (NASDAQ-GS: TROW) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a Maryland corporation listed on the Nasdaq Global Select Market, T. Rowe Price uses forms such as the Form 10-K, Form 10-Q, and Form 8-K to report on its financial condition, governance, and material corporate events.
Current and prospective investors in TROW can use these filings to understand how the firm’s global asset management business is evolving. Periodic reports detail results of operations and financial condition, including information about assets under management across equity, fixed income (including money market), multi-asset, and alternatives, as well as the significance of retirement-related assets and target date retirement portfolios. Form 8-K filings document events such as earnings releases, strategic collaborations, changes in board composition, and executive departures.
Because T. Rowe Price also operates in private markets through Oak Hill Advisors, its filings can provide context on how private credit and alternative strategies fit within the broader corporate structure. Governance-related disclosures outline board committee assignments, independence determinations, and other aspects of corporate oversight that may matter to long-term shareholders.
On Stock Titan, these SEC documents are updated as they are made available from EDGAR, and AI-powered summaries help explain key points from lengthy filings. Users can quickly identify important sections in annual reports (Form 10-K), quarterly reports (Form 10-Q), and current reports (Form 8-K), and can also review insider and executive-related disclosures when applicable. This combination of real-time access and AI-generated highlights is designed to make TROW’s regulatory record easier to interpret for investors who want to analyze the company’s financial reporting and governance in detail.
WILSON ALAN D reported acquisition or exercise transactions in this Form 4 filing.
PRICE T ROWE GROUP INC director Alan D. Wilson received an equity award of 557.9064 shares of Common Stock, valued at $89.03 per share. The award was made under the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan and relates to dividends declared on the company’s Common Stock.
A portion of these shares was credited as fully vested dividend reinvestment shares, while the remainder will accrue and vest when the corresponding grant vests. Following this award, Wilson directly holds a total of 38,765.9114 shares of Common Stock.
T. Rowe Price Group director Sandra S. Wijnberg acquired additional common stock through a share award. She received 187.2745 shares of Common Stock at $89.03 per share as a grant or other acquisition, bringing her direct holdings to 29,976.6947 shares.
According to the footnote, the shares were credited as fully vested dividend reinvestment shares under the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan in connection with dividends declared on the issuer’s common stock.
Verma Richard R. reported acquisition or exercise transactions in this Form 4 filing.
PRICE T ROWE GROUP INC director Richard R. Verma received a grant of 42.2582 shares of Common Stock valued at $89.0300 per share. The award was made under the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan as dividend equivalents that will accrue and vest when the corresponding grant vests. Following this award, Verma directly holds a total of 2936.2923 shares of Common Stock.
STEVENS ROBERT J reported acquisition or exercise transactions in this Form 4 filing.
PRICE T ROWE GROUP INC director Robert J. Stevens received a grant of 324.2828 shares of Common Stock, valued at $89.03 per share. The award was made under the company’s 2017 Non-Employee Director Equity Plan as dividend-related stock compensation. Following this transaction, he directly holds 22,532.6650 shares.
Smith Cynthia F reported acquisition or exercise transactions in this Form 4 filing.
PRICE T ROWE GROUP INC director Cynthia F. Smith received 61.1876 shares of Common Stock as a grant tied to dividends. The shares were valued at $89.03 per share on the transaction date and increased her directly held position to 6,729.5939 shares.
The award was made under the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan in connection with dividends declared on the company’s Common Stock. According to the disclosure, part of the award consists of fully-vested dividend reinvestment shares, while the remaining portion will vest when the related underlying director grant vests.
PRICE T ROWE GROUP INC director Robert F. MacLellan acquired 206.3598 shares of Common Stock as a fully vested grant under the company’s 2017 Non-Employee Director Equity Plan, tied to dividends on the stock. The shares were credited as dividend reinvestment, bringing his direct holdings to 52,965.8316 shares.
PRICE T ROWE GROUP INC director Allan C. Golston acquired additional common stock through a compensation grant. He received 42.2582 shares of common stock valued at $89.03 per share, credited as dividend equivalents under the 2017 Non-Employee Director Equity Plan. After this award, his direct holdings total 2,936.2923 shares.
PRICE T ROWE GROUP INC director Dina Dublon received a stock award credited as fully-vested dividend reinvestment shares under the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan. She acquired 137.7924 shares of Common Stock at $89.03 per share on March 30, 2026.
After this award, Dublon directly holds 13,525.4541 Common Stock shares. An additional 1,890.0000 shares are held indirectly through The Dina Dublon Family Trust, reflecting a separate indirect ownership position reported as a holding entry.
PRICE T ROWE GROUP INC director William P. Donnelly reported an acquisition of Common Stock through an equity plan–related dividend award. He received 152.0777 shares at a reference price of $89.03 per share, bringing his direct holdings to 10,567.0600 shares.
According to the disclosure, this transaction occurred under the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan in connection with dividends declared on the company’s Common Stock. A portion of the shares was credited as fully-vested dividend reinvestment shares, while the remainder will accrue and vest when the corresponding equity grant vests.
T Rowe Price Group Inc: The Vanguard Group filed Amendment No. 13 to a Schedule 13G/A reporting 0 shares beneficially owned and 0% of common stock following an internal realignment.
The filing explains that subsidiaries and business divisions of The Vanguard Group, Inc. will report ownership separately after the 01/12/2026 realignment; the form is signed by Ashley Grim on 03/27/2026.